Navigation Links
'From the Web to human diseases,' UH talk uncovers network similarities
Date:10/2/2008

made possible by grants from Tenneco Inc. and the National Endowment for the Humanities. The UH College of Natural Sciences and Mathematics and physics department are co-sponsoring Barabsi's appearance.

WHO:
Albert-Lszl Barabsi, renowned physicist

WHAT:
Tenneco Distinguished Lecture

WHEN:
5:30 to 6:30 p.m., Thursday, Oct. 9

WHERE:
University of Houston
Philip Guthrie Hoffman Hall
Room 232
Entrance 14 off Cullen Boulevard
http://www.uh.edu/campus_map/buildings/PGH.php


'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. AUDIO from Medialink and UnitedHealthcare: Medicare Annual Enrollment Begins November 15th
2. MidSouth eHealth Alliance to Transition to Commercial Software Solution from Informatics Corporation of America
3. Jefferson awarded multi-million dollar grant from National Eye Institute for new clinical trial
4. ZocDoc Celebrates 1st Anniversary with Investments from Bezos, Benioff
5. Texas Health Resources Receives Grant From Robert Wood Johnson Foundation to Support Prevention of Family Violence
6. AxoGen Awarded Accreditation from American Association of Tissue Banks : Decision Affirms AxoGen's Commitment to Safety and Ethicality in the Development and Distribution of AVANCE Nerve Graft for Treatment of Peripheral Nerve Injuries
7. VIDEO from Medialink and Philips: Microbubbles Developed to Administer Medications That Fight Cancer and Reduce Side Effects
8. Herley New England Receives Additional $1.3 Million Contract Award from Lockheed Martin for the Multi-Mission Helicopter
9. A Statement from Lung Cancer Alliance on the Death of Paul Newman
10. Statement From Carroll Schroeder, Executive Director for the California Alliance of Child and Family Services, on Californias 2008-2009 Final Budget:
11. China-Biotics, Inc. Sees No Impact on Its Business From Dairy Products Safety Concerns
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 2Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 3Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 4Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 5New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 1New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 2New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 3DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 1DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 2DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 3DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 4DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 5DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 6Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 1Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 2Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 3Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 4Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 5Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 6Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 7Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 8